Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oosterhuis

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Cardiovascular Pharmacology|January 1, 1993
Electrophysiologic and pharmacokinetic profile of the new antiarrhythmic drug TYB-3823 in humansH J Crijns, B Oosterhuis, A C Wiesfeld, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra-individual reproducibility and occurrence of adverse eventsW J Tamminga, J Wemer, B Oosterhuis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1995
Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur)B Oosterhuis, M D Brannan, H Groen, et al.
Therapeutic Drug Monitoring|January 1, 1988
No effect of influenza vaccination on theophylline pharmacokinetics as studied by ultraviolet spectrophotometry, HPLC, and EMIT assay methodsJ H Jonkman, A S Wymenga, R A de Zeeuw, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepineP N van Heiningen, M D Eve, B Oosterhuis, et al.
European Journal of Clinical Pharmacology|June 22, 2001
An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19W J Tamminga, J Wemer, B Oosterhuis, et al.
British Journal of Clinical Pharmacology|May 8, 2002
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malariaS Looareesuwan, B Oosterhuis, B M Schilizzi, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Absorption, metabolism and excretion of a single oral dose of (14)C-repaglinide during repaglinide multiple dosingP N van Heiningen, V Hatorp, K Kramer Nielsen, et al.
The American Journal of Tropical Medicine and Hygiene|February 28, 2001
A randomized controlled trial of artemotil (beta-arteether) in Zambian children with cerebral malariaP E Thuma, G J Bhat, G F Mabeza, et al.
Journal of Cardiovascular Pharmacology|March 1, 1994
Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular functionY S Tuininga, H J Crijns, B Oosterhuis, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Cardiovascular Pharmacology|January 1, 1993
Electrophysiologic and pharmacokinetic profile of the new antiarrhythmic drug TYB-3823 in humansH J Crijns, B Oosterhuis, A C Wiesfeld, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra-individual reproducibility and occurrence of adverse eventsW J Tamminga, J Wemer, B Oosterhuis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1995
Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur)B Oosterhuis, M D Brannan, H Groen, et al.
Therapeutic Drug Monitoring|January 1, 1988
No effect of influenza vaccination on theophylline pharmacokinetics as studied by ultraviolet spectrophotometry, HPLC, and EMIT assay methodsJ H Jonkman, A S Wymenga, R A de Zeeuw, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepineP N van Heiningen, M D Eve, B Oosterhuis, et al.
European Journal of Clinical Pharmacology|June 22, 2001
An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19W J Tamminga, J Wemer, B Oosterhuis, et al.
British Journal of Clinical Pharmacology|May 8, 2002
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malariaS Looareesuwan, B Oosterhuis, B M Schilizzi, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Absorption, metabolism and excretion of a single oral dose of (14)C-repaglinide during repaglinide multiple dosingP N van Heiningen, V Hatorp, K Kramer Nielsen, et al.
The American Journal of Tropical Medicine and Hygiene|February 28, 2001
A randomized controlled trial of artemotil (beta-arteether) in Zambian children with cerebral malariaP E Thuma, G J Bhat, G F Mabeza, et al.
Journal of Cardiovascular Pharmacology|March 1, 1994
Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular functionY S Tuininga, H J Crijns, B Oosterhuis, et al.
Pageof 6